Table 3.
Age group | 1987 | 2002 (peak incidence) | 2008 |
---|---|---|---|
50-69: | |||
Hormone treatment attributable proportion | 0.07 | 0.27 | 0.13 |
Screening attributable proportion | 0.00 | 0.23 | 0.17 |
All studied age groups*: | |||
Hormone treatment attributable proportion | 0.04 | 0.19 | 0.09 |
Screening attributable proportion | 0.00 | 0.12 | 0.08 |
*Age 30-90 years.